It’s easy to see how Arena Pharmaceuticals grew to be a fragmented and strained biopharma company.
Founded in 1997, the San Diego, California startup was dedicated to the research and development of drugs targeting G-protein-coupled receptors (GPCRs).
Out of its preclinical research came a number of promising candidates. Among them; lorcaserin, a potential weight loss therapy.
